Q2 2022 Holdings
Filed 2022-08-15 | 43 holdings | $36.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Biosciences Inc(WHWK) | COM | 00032Q104 | $18.8M | 1,529,402 | 51.9% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $7.2M | 267,195 | 19.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.2M | 167,500 | 11.7% |
| Aclaris Therapeu(ACRS) | COM | 00461U105 | $2.7M | 192,835 | 7.4% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $2.2M | 61,926 | 6.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.0M | 71,500 | 2.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $25.1K | 554,000 | 0.1% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $10.0K | 11,361,451 | 0.0% |
| Kura Oncology Inc. Common Stock(KURA) | COM | 50127T109 | $9.8K | 536,500 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.3K | 843,122 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.3K | 272,500 | 0.0% |
| Bellus Health Inc(BLU) | COM NEW | 07987C204 | $7.5K | 816,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $6.7K | 352,500 | 0.0% |
| Mirati Therapeutics(MRTXEUR) | COM | 60468T105 | $6.3K | 94,500 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.6K | 562,500 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.4K | 563,607 | 0.0% |
| Roche GS | COM | 993960LE1 | $5.3K | 16,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.9K | 205,003 | 0.0% |
| Health Sciences Acquisitions | ORD SHS | G4411D109 | $3.9K | 392,500 | 0.0% |
| Merus BV | COM | N5749R100 | $3.5K | 154,000 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $3.3K | 2,050,359 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.1K | 13,000 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $2.9K | 35,888 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $2.8K | 457,200 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.7K | 234,026 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $2.4K | 243,250 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.4K | 303,396 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $2.2K | 152,500 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $2.1K | 645,136 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.7K | 154,356 | 0.0% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $1.5K | 645,149 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $1.5K | 122,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.3K | 27,500 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $1.3K | 62,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $980 | 200,000 | 0.0% |
| AC Immune SACall | COM | 99P1VHX22 | $354 | 100,000 | 0.0% |
| Athira Pharma IncCall | COM | 99P19TV23 | $340 | 100,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $268 | 32,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $232 | 200,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $123 | 5,000 | 0.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $98 | 35,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $53 | 13,171 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $25 | 90,832 | 0.0% |